Cargando…
Correction: CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101942/ https://www.ncbi.nlm.nih.gov/pubmed/37055395 http://dx.doi.org/10.1038/s41408-023-00825-7 |
_version_ | 1785025600565542912 |
---|---|
author | Niu, Jiahua Qiu, Huiying Xiang, Fang Zhu, Lin Yang, Jun Huang, Chongmei Zhou, Kun Tong, Yin Cai, Yu Dong, Baoxia Lu, Yuan Sun, Xuedong Wan, Liping Ding, Xueying Wang, Haopeng Song, Xianmin |
author_facet | Niu, Jiahua Qiu, Huiying Xiang, Fang Zhu, Lin Yang, Jun Huang, Chongmei Zhou, Kun Tong, Yin Cai, Yu Dong, Baoxia Lu, Yuan Sun, Xuedong Wan, Liping Ding, Xueying Wang, Haopeng Song, Xianmin |
author_sort | Niu, Jiahua |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10101942 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-101019422023-04-15 Correction: CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study Niu, Jiahua Qiu, Huiying Xiang, Fang Zhu, Lin Yang, Jun Huang, Chongmei Zhou, Kun Tong, Yin Cai, Yu Dong, Baoxia Lu, Yuan Sun, Xuedong Wan, Liping Ding, Xueying Wang, Haopeng Song, Xianmin Blood Cancer J Correction Nature Publishing Group UK 2023-04-13 /pmc/articles/PMC10101942/ /pubmed/37055395 http://dx.doi.org/10.1038/s41408-023-00825-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Correction Niu, Jiahua Qiu, Huiying Xiang, Fang Zhu, Lin Yang, Jun Huang, Chongmei Zhou, Kun Tong, Yin Cai, Yu Dong, Baoxia Lu, Yuan Sun, Xuedong Wan, Liping Ding, Xueying Wang, Haopeng Song, Xianmin Correction: CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study |
title | Correction: CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study |
title_full | Correction: CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study |
title_fullStr | Correction: CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study |
title_full_unstemmed | Correction: CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study |
title_short | Correction: CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study |
title_sort | correction: cd19/cd22 bispecific car-t cells for mrd-positive adult b cell acute lymphoblastic leukemia: a phase i clinical study |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101942/ https://www.ncbi.nlm.nih.gov/pubmed/37055395 http://dx.doi.org/10.1038/s41408-023-00825-7 |
work_keys_str_mv | AT niujiahua correctioncd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT qiuhuiying correctioncd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT xiangfang correctioncd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT zhulin correctioncd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT yangjun correctioncd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT huangchongmei correctioncd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT zhoukun correctioncd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT tongyin correctioncd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT caiyu correctioncd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT dongbaoxia correctioncd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT luyuan correctioncd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT sunxuedong correctioncd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT wanliping correctioncd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT dingxueying correctioncd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT wanghaopeng correctioncd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy AT songxianmin correctioncd19cd22bispecificcartcellsformrdpositiveadultbcellacutelymphoblasticleukemiaaphaseiclinicalstudy |